Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Justice

###### Drug Enforcement Administration

# ACTION:

60-Day Notice of Information Collection Under Review: Prescription Monitoring Program Questionnaire.

The Department of Justice (DOJ), Drug Enforcement Administration (DEA), has submitted the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection is published to obtain comments from the public and affected agencies. Comments are encouraged and will be accepted for “sixty days” until December 2, 2005. This process is conducted in accordance with 5 CFR 1320.10.

If you have comments, especially on the estimated public burden or associated response time, suggestions, or need a copy of the proposed information collection instrument with instructions or additional information, please contact Patricia M. Good, Chief, Liaison and Policy Section, Office of Diversion Control, Drug Enforcement Administration, Washington, DC 20537.

Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points:

—Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility;

—Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used;

—Enhance the quality, utility, and clarity of the information to be collected; and

                    —Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological                           ( print page 57623)                        collection techniques or other forms of information technology,                     *e.g.*, permitting electronic submission of responses.                

Overview of this information collection:

                    (1)                     *Type of Information Collection:*                     Extension of a currently approved collection.                

                    (2)                     *Title of the Form/Collection:*                     Prescription Drug Monitoring Program Questionnaire.                

                    (3)                     *Agency form number, if any, and the applicable component of the Department of Justice sponsoring the collection:*                     Form Number: None. Office of Diversion Control, Drug Enforcement Administration, Department of Justice.                

                    (4)                     *Affected public who will be asked or required to respond, as well as a brief abstract:*                     Primary: States. Other: None. This questionnaire permits the Drug Enforcement Administration to compile and evaluate information regarding the design, implementation and operation of state prescription monitoring programs. Such information allows DEA to assist states in the development of new programs designed to enhance the ability of both DEA and state authorities to prevent, detect, and investigate the diversion and abuse of controlled substances.                

                    (5)                     *An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond:*                     It is estimated that 26 persons complete the Prescription Monitoring Program Questionnaire on paper and 25 electronically, at 5 hours per form, for an annual burden of 255 hours.                

                    (6)                     *An estimate of the total public burden (in hours) associated with the collection:*                     It is estimated that there are 255 burden hours associated with this collection.                

If additional information is required contact: Brenda E. Dyer, Department Clearance Officer, United States Department of Justice, Justice Management Division, Policy and Planning Staff, Patrick Henry Building, Suite 1600, 601 D Street, NW., Washington, DC 20530.

Dated: September 28, 2005.

Brenda E. Dyer,

Department Clearance Officer, Department of Justice.

[FR Doc. 05-19735 Filed 9-30-05; 8:45 am]

BILLING CODE 4410-09-P